Market Cap
$12.66 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $204.45 B |
Danaher | $177.21 B |
Siemens Healthineers AG | $63.84 B |
DexCom, Inc. | $45.21 B |
Lonza Group Ltd | $39.85 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Revvity, Inc., formerly part of PerkinElmer, Inc., offers solutions for diagnostics and life sciences markets globally. It provides tools for life science research, environmental analysis, industrial processes, and genomic workflows via two segments: Discovery & Analytical Solutions and Diagnostics. The latter focuses on early disease detection, including genetic disorders. Established in 1937, it serves a broad range of sectors, from pharmaceuticals to academia.
Revvity, Inc. has the following listings and related stock indices.
Stock: NYSE: RVTY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.